```html

Quasi‑Uniparental Disomy (QUPD): A Patient‑Focused Medical Guide

Overview

Quasi‑uniparental disomy (QUPD) is a rare chromosomal anomaly in which a person inherits two copies of a chromosome (or part of a chromosome) from one parent and no copy from the other parent, but unlike classic uniparental disomy the two copies are not identical. The “quasi” prefix reflects that the two chromosomes are genetically distinct (they result from recombination events) yet both originate from the same parent. This can lead to abnormal gene dosage—either excess or deficiency of genes—producing a spectrum of clinical manifestations.

Who it affects: QUPD can occur in any individual, regardless of sex or ethnicity, because it results from random errors during meiosis or early embryonic cell division. The condition is most often identified in infants or children undergoing genetic testing for developmental delay, growth problems, or congenital anomalies.

Prevalence: Exact population numbers are unknown due to under‑recognition, but estimates suggest QUPD is present in less than 1 in 10,000 live births. It accounts for a small proportion of all uniparental disomy (UPD) cases, which overall affect roughly 1 in 2,000–3,000 births [1] NIH. Recent next‑generation sequencing studies have identified QUPD in 0.2–0.4 % of cohorts evaluated for unexplained neurodevelopmental disorders [2] Genome Medicine.

Symptoms

The clinical picture of QUPD varies widely depending on which chromosome is involved and which imprinted (parent‑specific) genes are affected. Below is a comprehensive list of reported symptoms, grouped by organ system.

Neurological & Developmental

• Intellectual disability – ranging from mild learning difficulties to profound impairment.
• Developmental delay – delayed motor milestones (rolling, sitting, walking) and speech acquisition.
• Autism spectrum features – impaired social interaction, repetitive behaviors.
• Seizures – focal or generalized; may be refractory to first‑line therapy.
• Hypotonia – low muscle tone causing floppy infant syndrome.

Growth & Endocrine

• Failure to thrive – low weight/height percentile despite adequate nutrition.
• Growth hormone deficiency – short stature, delayed bone age.
• Pubertal abnormalities – precocious or delayed puberty.
• Thyroid dysfunction – hypo‑ or hyper‑thyroidism (especially with chromosome 14 QUPD).

Facial & Craniofacial

• Distinctive facial features such as:
  • Broad forehead
  • Thin upper lip
  • Epicanthal folds
  • Low-set ears
• Micrognathia (small jaw) or macroglossia (large tongue) when imprinted growth‑regulating genes are involved.

Cardiovascular

• Congenital heart defects – ventricular septal defect (VSD), atrial septal defect (ASD), or coarctation of the aorta.
• Cardiomyopathy – rare but reported with chromosome 7 QUPD.

Renal & Urinary

• Structural anomalies – renal agenesis or dysplasia.
• Nephrotic‑type proteinuria in some imprinting disorders.

Other Systems

• Hearing loss – sensorineural, particularly with chromosome 15 involvement.
• Vision problems – strabismus or refractive errors.
• Skin abnormalities – café‑au‑lait spots, hypopigmented macules.

Causes and Risk Factors

QUPD is not inherited in the classic Mendelian sense; it arises from errors during the formation of gametes (sperm or egg) or after fertilization.

Mechanisms

• Meiotic nondisjunction – the parental chromosomes fail to separate, leading to a gamete with two copies of the same chromosome.
• Trisomy rescue – an embryo initially has three copies of a chromosome; loss of the paternal (or maternal) copy can leave two maternal (or paternal) copies that are genetically distinct because of recombination.
• Post‑zygotic mitotic recombination – a somatic cell division error creates a region of isodisomy (identical) surrounded by heterodisomy (different), giving the “quasi” pattern.

Risk Factors

• Advanced parental age – especially maternal age >35, which raises the risk of meiotic errors [3] CDC.
• Previous child with a chromosomal abnormality – suggests a predisposition to meiotic mishaps.
• Assisted reproductive technologies (ART) – some reports indicate a slightly higher incidence of UPD‑related anomalies after in‑vitro fertilization [4] Fertility and Sterility.
• Environmental exposures – high‑dose radiation or certain teratogenic chemicals during gametogenesis may increase the chance of nondisjunction.

Diagnosis

Because QUPD presents with nonspecific symptoms, a high index of suspicion is required. Diagnosis follows a stepwise approach:

1. Clinical Evaluation

• Comprehensive medical history (growth charts, developmental milestones, family history).
• Physical examination focusing on dysmorphic features, neurologic tone, and organ system screening.

2. Genetic Testing

• Chromosomal microarray (CMA) – detects copy‑number changes and regions of homozygosity that suggest uniparental disomy.
< Single‑nucleotide polymorphism (SNP) array – provides detailed genotype patterns to differentiate heterodisomy from isodisomy and to identify “quasi” patterns.
• Whole‑exome or whole‑genome sequencing (WES/WGS) – increasingly used; can reveal parental origin of each allele when combined with parental sample sequencing.
• Methylation analysis – essential for chromosomes with imprinted regions (e.g., 15, 14, 7). Abnormal methylation patterns confirm parental‑origin imbalance.

3. Ancillary Tests

• Brain MRI – to assess structural anomalies or cortical malformations.
• Echocardiogram – screening for congenital heart disease.
• Renal ultrasound – evaluates kidney anatomy.
• Endocrine panel – thyroid function, growth hormone levels, cortisol.

4. Confirmatory Steps

Parental DNA is almost always required to prove that both copies originated from the same parent. Trio‑based analysis (patient + both parents) is the gold standard [5] American Journal of Human Genetics.

Treatment Options

There is no cure that eliminates the underlying chromosomal configuration; treatment focuses on managing individual symptoms and preventing complications.

Medical Management

• Anticonvulsants – tailored to seizure type (e.g., levetiracetam, valproate). Regular EEG monitoring is recommended.
• Growth hormone therapy – indicated for documented deficiency; improves height velocity [6] Pediatric Endocrinology Review.
• Thyroid hormone replacement – levothyroxine for hypothyroidism; dosage guided by TSH/T4 levels.
• Hormone replacement for pubertal delay – estrogen or testosterone patches as appropriate.
• Cardiac medications – beta‑blockers or ACE inhibitors for structural heart disease, per cardiology guidelines.
• Renal supportive care – ACE inhibitors or ARBs for proteinuria, nephrology follow‑up.

Therapeutic Interventions

• Early intervention services – speech, occupational, and physical therapy to address developmental delays.
• Behavioral therapy – applied behavior analysis (ABA) for autism spectrum features.
• Special education – individualized education plans (IEPs) in school settings.
• Surgical correction – repair of congenital heart defects, cleft palate, or orthopedic deformities when indicated.

Lifestyle & Supportive Measures

• Balanced nutrition with high‑calorie formulas if failure to thrive persists.
• Regular physical activity adapted to the child’s ability to improve tone and cardiopulmonary health.
• Family counseling and support groups (e.g., Rare Chromosome Disorder Foundation).

Living with Quasi‑Uniparental Disomy

Families often wonder how to navigate daily life. Below are practical tips:

• Establish a multidisciplinary care team – pediatrician, clinical geneticist, neurologist, endocrinologist, cardiologist, and therapists.
• Maintain an up‑to‑date health record – include genetic reports, growth charts, medication lists, and emergency contacts.
• Routine monitoring schedule:
  • Every 3–6 months: growth parameters, endocrine labs, and developmental assessments.
  • Annually: cardiac echo, renal ultrasound, and audiology evaluation.
  • Every 1–2 years: neuropsychological testing to guide educational planning.
• Medication adherence – use pill organizers or dosing apps; set alarms for morning/evening doses.
• Safety planning – if seizures occur, teach caregivers seizure first‑aid and consider a seizure‑alert device.
• School advocacy – provide the school with a copy of the IEP and a summary of medical needs; request accommodations such as extra time for tests.
• Psychosocial support – connect with peer groups; mental health counseling can help address frustration, anxiety, or depression in both the child and caregivers.

Prevention

Because QUPD arises from random chromosomal events, primary prevention is limited. However, certain actions can reduce overall risk of chromosomal abnormalities:

• Pre‑conception counseling for couples of advanced maternal age.
• Optimizing maternal health (folic acid supplementation, avoidance of smoking/alcohol, control of chronic illnesses).
• Consider genetic carrier screening and discuss reproductive options (e.g., pre‑implantation genetic testing) with a reproductive specialist.
• When using assisted reproductive technologies, select clinics with robust embryo‑genetic testing protocols.

Complications

If underlying abnormalities are not recognized or treated, several complications may develop:

• Progressive intellectual decline due to uncontrolled seizures or untreated metabolic imbalances.
• Severe growth failure leading to short stature and osteoporosis.
• Cardiovascular morbidity – heart failure or arrhythmias from uncorrected structural defects.
• Renal insufficiency – chronic kidney disease from persistent proteinuria or congenital anomalies.
• Psychiatric disorders – increased risk of anxiety, mood disorders, and behavioral problems.
• Reduced life expectancy in rare cases where multiple organ systems are profoundly affected.

When to Seek Emergency Care

References

1. National Institutes of Health (NIH). “Uniparental Disomy.” Genetics Home Reference. 2022.
2. Wang, X. et al. “Quasi‑uniparental disomy identified by whole‑genome sequencing in a cohort of neurodevelopmental disorders.” Genome Medicine, 2021.
3. Centers for Disease Control and Prevention (CDC). “Advanced Maternal Age and Birth Defects.” 2023.
4. Jiang, Y. et al. “Incidence of uniparental disomy in children conceived by assisted reproductive technology.” Fertility and Sterility, 2020.
5. McGaughran, J., et al. “Trio‑based SNP array for detection of uniparental disomy and quasi‑uniparental disomy.” American Journal of Human Genetics, 2022.
6. Rosenbloom, A. “Growth Hormone Therapy in Children with Genetic Syndromes.” Pediatric Endocrinology Review, 2020.

```